维普中文期刊产品整合服务
8篇 您的检索式:作者名="Sautera"
    题名 作者 年代 出处 被引量
1Pharmacokinetics, immunogenicity and safety of bivatozumab mertansine, a novel CD44 v6 -targe -ring immunoconjugate, in patientswith squamous cell carcinoma of the head and neck 显示文摘Sautera Kloft C Gronau S 2007Int J Oncol2007,30,4:1
2A new non-degrading isolation process for 1,3-β-D-glucan of high purity from baker' s yeast Saccharomyces cerevisiae 显示文摘Stefan Freimunda Martin Sautera Othmar Kappeli 2003Carbohydrate Polymers2003,,54:1
3Intestinal development in neonatal calves: effects of glucocorticoids and dependence on colostnan feeding显示文摘Sautera B S N Rofflera B Philipona C 2004Biol Neonate2004,85,:1
4A new nondegrading isolation process for 1,3-β--glucan of high purity from baker's yeast Saccharomyces cerevisiae显示文摘Stefan Freimund Martin Sautera Othmar Kappelib 0,,02:1
5A new non-degrading isolation process for 1,3-β-D-glucan of high purity from baker's yeast Saccharomyces cerevisiae 显示文摘Stefan Freinmnd Martin Sautera 2003Carbohydrate Polymers2003,54,9:1
6Pharmacokinetics, immunogenicityand safety of bivatuzumab mertansine, a novel CD44v6 targeting immuno-conjugate, in patientswith squamous cell carcinoma of the head and neck显示文摘SauterA Kloft C Gronau S 2007Int J Oncol2007,30,4:1
7A new non-degrading isolation process for 1,3-13-D -glucan of high purity from baker' s yeast Saccharomyces cerevisiae 显示文摘Stefan Freimund Martin Sautera Othmar K/:ppelib 2003Carbohydrate Polymers2003,,15:1
8Pharmacokinetics, immunoge- nicity and safety of bivatuzumab mertansine, a novel CIM4v6 targe- ting immunoconjugate, in patientswith squamous cell carcinoma of the head and neck显示文摘SauterA Kloft C Gronau S 2007Int J Oncol2007,30,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费